Lung Cancer Treatment with Two Chemotherapy Drugs Yields Positive Resu

Non Small cell lung cancer is a difficult disease to treat. Chemotherapy has in general not be satisfactory.

In a recent study presented at ASCO (American Socitey for Clinical Oncology) two drugs, Carboplatin plus Paclitaxel in combination improved survical compared to single agent therapy.

Treatment for lung cancer is improving. We hope this trend will accelerate, and we look forward to even better reported results in the near future.

Webmaster

September 07, 2002